Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tromp

Showing results (1201-1210 of 1,251) with videos related to

Pageof 126
Sort By:
ESC Heart Failure|February 1, 2023
Titration of medications and outcomes in multi-ethnic heart failure cohorts (with reduced ejection fraction) from Singapore and New ZealandTiew-Hwa Katherine Teng, Wan Ting Tay, Wouter Ouwerkerk, et al.
The Lancet. Oncology|April 3, 2025
Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patients with folate receptor α-positive, platinum-resistant ovarian cancer: a randomised, open-label, phase 3 trialToon Van Gorp, Kathleen N Moore, Gottfried E Konecny, et al.
Journal of the American Medical Informatics Association : JAMIA|September 6, 2015
Desiderata for computable representations of electronic health records-driven phenotype algorithmsHuan Mo, William K Thompson, Luke V Rasmussen, et al.
Journal of the National Cancer Institute|November 21, 2025
Health-related quality of life with first- vs second-line CDK4/6 inhibitor use in advanced breast cancer: results from the SONIA trialNoor Wortelboer, Seamus Kent, Hedwig M Blommestein, et al.
JAMA Cardiology|December 1, 2017
Genetic Association of Lipids and Lipid Drug Targets With Abdominal Aortic Aneurysm: A Meta-analysisSeamus C Harrison, Michael V Holmes, Stephen Burgess, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 3, 2019
The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failureBernadet T Santema, Michelle M Y Chan, Jasper Tromp, et al.
Nature|November 28, 2024
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancerGabe S Sonke, Annemiek van Ommen-Nijhof, Noor Wortelboer, et al.
Journal of Cardiovascular Translational Research|July 22, 2015
A Robust e-Epidemiology Tool in Phenotyping Heart Failure with Differentiation for Preserved and Reduced Ejection Fraction: the Electronic Medical Records and Genomics (eMERGE) NetworkSuzette J Bielinski, Jyotishman Pathak, David S Carrell, et al.
International Journal of Biomedical Data Mining|April 8, 2016
ePhenotyping for Abdominal Aortic Aneurysm in the Electronic Medical Records and Genomics (eMERGE) Network: Algorithm Development and Konstanz Information Miner WorkflowKenneth M Borthwick, Diane T Smelser, Jonathan A Bock, et al.
Frontiers in Genetics|June 29, 2019
A <i>Trans</i>-Ethnic Genome-Wide Association Study of Uterine FibroidsTodd L Edwards, Ayush Giri, Jacklyn N Hellwege, et al.
Pageof 126

Showing results (1201-1210 of 1,251) with videos related to

Sort By:
Pageof 126
ESC Heart Failure|February 1, 2023
Titration of medications and outcomes in multi-ethnic heart failure cohorts (with reduced ejection fraction) from Singapore and New ZealandTiew-Hwa Katherine Teng, Wan Ting Tay, Wouter Ouwerkerk, et al.
The Lancet. Oncology|April 3, 2025
Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patients with folate receptor α-positive, platinum-resistant ovarian cancer: a randomised, open-label, phase 3 trialToon Van Gorp, Kathleen N Moore, Gottfried E Konecny, et al.
Journal of the American Medical Informatics Association : JAMIA|September 6, 2015
Desiderata for computable representations of electronic health records-driven phenotype algorithmsHuan Mo, William K Thompson, Luke V Rasmussen, et al.
Journal of the National Cancer Institute|November 21, 2025
Health-related quality of life with first- vs second-line CDK4/6 inhibitor use in advanced breast cancer: results from the SONIA trialNoor Wortelboer, Seamus Kent, Hedwig M Blommestein, et al.
JAMA Cardiology|December 1, 2017
Genetic Association of Lipids and Lipid Drug Targets With Abdominal Aortic Aneurysm: A Meta-analysisSeamus C Harrison, Michael V Holmes, Stephen Burgess, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 3, 2019
The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failureBernadet T Santema, Michelle M Y Chan, Jasper Tromp, et al.
Nature|November 28, 2024
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancerGabe S Sonke, Annemiek van Ommen-Nijhof, Noor Wortelboer, et al.
Journal of Cardiovascular Translational Research|July 22, 2015
A Robust e-Epidemiology Tool in Phenotyping Heart Failure with Differentiation for Preserved and Reduced Ejection Fraction: the Electronic Medical Records and Genomics (eMERGE) NetworkSuzette J Bielinski, Jyotishman Pathak, David S Carrell, et al.
International Journal of Biomedical Data Mining|April 8, 2016
ePhenotyping for Abdominal Aortic Aneurysm in the Electronic Medical Records and Genomics (eMERGE) Network: Algorithm Development and Konstanz Information Miner WorkflowKenneth M Borthwick, Diane T Smelser, Jonathan A Bock, et al.
Frontiers in Genetics|June 29, 2019
A <i>Trans</i>-Ethnic Genome-Wide Association Study of Uterine FibroidsTodd L Edwards, Ayush Giri, Jacklyn N Hellwege, et al.
Pageof 126